CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NEOSETAC project aims to explore a novel selenium-based therapy for breast cancer treatment. It focuses on improving drug delivery and targeting to enhance therapeutic efficacy while minimizing side effects.
The European Chronic Diseases Alliance has defined cancer as one of the major non-communicable diseases, accountingfor 13% of the deaths worldwide, resulting in 8.2 million deaths annually.
In the NEOSETAC project, breast cancer will be thefocus of study being the most common cancers in women.
It comprises of 10.4% of all the cancer incidences among women,causing 411 093 deaths per year overall the world.
In Europe, there is more than twice of the amount of new breast cancercases annually than n…
UNIVERSITAT AUTONOMA DE BARCELONA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, CERDANYOLA DEL VALLES
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
QUALIZYME DIAGNOSTICS GMBH & CO KG
Austria, Graz
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
